Table 2.
Clinical presentation of COVID-19 patients. Clinical and laboratory variables investigated as potential predictors. Gastrointestinal symptoms: diarrhea, vomiting or abdominal pain. SatO2/FiO2: Peripheral oxygen saturation /inspiratory oxygen fraction (room air or oxygen therapy). * Predictors in the definitive prognostic prediction models.
| INTERVAL SINCE SYMPTOMS ONSET | Average +/- sd (range) |
|---|---|
| Days | 6,8 +/- 4,5 (0-30) |
| SYMPTOMS Total No. 441 | No. (%) |
|---|---|
| Fever | 361 (82) |
| Cough | 287 (65,2) |
| Dyspnea | 178 (40,4) |
| General dyscomphort/Asthenia | 171 (38,9) |
| Gastrointestinal symptoms | 103 (23,4) |
| Myalgias | 72 (16,4) |
| Headache | 47 (10,7) |
| Hyposmia/Dysgeusia | 32 (7,3) |
| OXYGEN SATURATION | Average +/- sd (range) |
|---|---|
| Sat 02 (air room) | 93,7 +/- 5,6 (55-100) |
| Sat 02 /Fi O2* | 443,5 +/-34,4 |
| LABORATORY DATA | Average/ Min / 25% / Median / 75% / Max |
|---|---|
| Lactic dehydrogenase (U/l) * | 306 / 16 / 218,2 / 265,5 / 349,7 / 2146 |
| C reactive protein (mg/l) * | 81 / 0,3 / 15,5 / 44,6 / 117,2 / 655,5 |
| Lymphocytes count (x103µ/l) * | 1,2 / 0,06 / 0,7 / 1 / 1,4 /12,3 |
| Platelets count (x103µ/l) * | 203,7 / 32 / 150 / 193 / 242 / 716 |
| Dimer D (ng/l) * | 1390 / 83 / 350 / 608 / 1015 / 38282 |